FI851529A0 - Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus - Google Patents

Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus

Info

Publication number
FI851529A0
FI851529A0 FI851529A FI851529A FI851529A0 FI 851529 A0 FI851529 A0 FI 851529A0 FI 851529 A FI851529 A FI 851529A FI 851529 A FI851529 A FI 851529A FI 851529 A0 FI851529 A0 FI 851529A0
Authority
FI
Finland
Prior art keywords
polypeptides
preparation
gamma interferon
human gamma
sequences
Prior art date
Application number
FI851529A
Other languages
English (en)
Swedish (sv)
Other versions
FI851529L (fi
FI90436B (fi
FI90436C (fi
Inventor
Joachim Engels
Michael Leineweber
Eugen Uhlmann
Wolfgang Ulmer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI851529A0 publication Critical patent/FI851529A0/fi
Publication of FI851529L publication Critical patent/FI851529L/fi
Publication of FI90436B publication Critical patent/FI90436B/fi
Application granted granted Critical
Publication of FI90436C publication Critical patent/FI90436C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon
FI851529A 1984-04-19 1985-04-17 Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus FI90436C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414831 1984-04-19
DE19843414831 DE3414831A1 (de) 1984-04-19 1984-04-19 Herstellung von polypeptiden mit human-gammainterferon-aktivitaet

Publications (4)

Publication Number Publication Date
FI851529A0 true FI851529A0 (fi) 1985-04-17
FI851529L FI851529L (fi) 1985-10-20
FI90436B FI90436B (fi) 1993-10-29
FI90436C FI90436C (fi) 1994-02-10

Family

ID=6234006

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851529A FI90436C (fi) 1984-04-19 1985-04-17 Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus

Country Status (20)

Country Link
US (1) US4832959A (fi)
EP (1) EP0161504B1 (fi)
JP (2) JPH0745516B2 (fi)
KR (1) KR920009505B1 (fi)
AT (1) ATE69241T1 (fi)
CA (1) CA1339892C (fi)
DE (2) DE3414831A1 (fi)
DK (1) DK164940C (fi)
ES (1) ES542337A0 (fi)
FI (1) FI90436C (fi)
GR (1) GR850941B (fi)
HU (1) HU210111B (fi)
IE (1) IE59460B1 (fi)
IL (1) IL74947A (fi)
MA (1) MA20411A1 (fi)
NO (1) NO171983C (fi)
NZ (1) NZ211827A (fi)
PH (1) PH25251A (fi)
PT (1) PT80300B (fi)
ZA (1) ZA852900B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
US5157004A (en) * 1986-12-27 1992-10-20 Takeda Chemical Industries, Ltd. Polypeptides and production thereof
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
CA2607806A1 (en) * 2005-05-04 2006-11-16 Nautilus Biotech, S.A. Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
WO2008121461A2 (en) * 2007-02-26 2008-10-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Vaccine for activating helper function of cd8+ tcells
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) * 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
JP4821891B2 (ja) * 2009-07-01 2011-11-24 トヨタ自動車株式会社 電池制御システム及び車両
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
WO2020076970A1 (en) 2018-10-11 2020-04-16 Inhibrx, Inc. B7h3 single domain antibodies and therapeutic compositions thereof
US20210380679A1 (en) 2018-10-11 2021-12-09 Inhibrx, Inc. Dll3 single domain antibodies and therapeutic compositions thereof
WO2020077257A1 (en) 2018-10-11 2020-04-16 Inhibrx, Inc. Pd-1 single domain antibodies and therapeutic compositions thereof
US20210340273A1 (en) 2018-10-11 2021-11-04 Inhlbrx, inc. 5t4 single domain antibodies and therapeutic compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
IE850995L (en) 1985-10-19
DK176285D0 (da) 1985-04-18
PT80300B (pt) 1987-09-30
IL74947A (en) 2000-06-01
FI851529L (fi) 1985-10-20
NO851564L (no) 1985-10-21
FI90436B (fi) 1993-10-29
EP0161504B1 (de) 1991-11-06
PH25251A (en) 1991-03-27
IL74947A0 (en) 1985-08-30
HU210111B (en) 1995-02-28
ZA852900B (en) 1985-11-27
ATE69241T1 (de) 1991-11-15
JPH07100037B2 (ja) 1995-11-01
CA1339892C (en) 1998-06-02
DK164940C (da) 1993-02-01
JPH06153957A (ja) 1994-06-03
NO171983B (no) 1993-02-15
JPH0745516B2 (ja) 1995-05-17
PT80300A (de) 1985-05-01
ES8603574A1 (es) 1985-12-16
DK176285A (da) 1985-10-20
NZ211827A (en) 1988-07-28
KR850007274A (ko) 1985-12-02
GR850941B (fi) 1985-11-25
KR920009505B1 (ko) 1992-10-17
DE3584579D1 (de) 1991-12-12
MA20411A1 (fr) 1985-12-31
FI90436C (fi) 1994-02-10
ES542337A0 (es) 1985-12-16
EP0161504A1 (de) 1985-11-21
IE59460B1 (en) 1994-02-23
DK164940B (da) 1992-09-14
JPS60233100A (ja) 1985-11-19
NO171983C (no) 1993-05-26
HUT37815A (en) 1986-02-28
DE3414831A1 (de) 1985-10-31
US4832959A (en) 1989-05-23

Similar Documents

Publication Publication Date Title
FI851529A0 (fi) Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus
FI853056L (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
ATE127694T1 (de) Lebende impfstoffe.
ZA909762B (en) Process for the production of biologically active protein
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
EP0226448A3 (en) Solubilisation of protein aggregates
DE3855523T2 (de) Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
DE68918673T2 (de) IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung.
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
PT80542A (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0315118A3 (en) Dna coding for endothelin and use thereof
DE3689921D1 (de) Menschlicher plazentarer angiogenischer Faktor, geeignet für die Reizung der Kapillarsynthese, der Endothelzellprotease, der DNS-Synthese und der Absiedlung.
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ES8603571A1 (es) Un procedimiento para preparar gamma-interferon de humano
DE3685744T2 (de) Fraktion von listeria monocytogenes mit therapeutischer wirkung, verfahren fuer ihre herstellung und diese enthaltende pharmazeutische zusammensetzung.
BG60106A3 (en) Method for seaweed cultivation

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT